John B. Stuppin is Director at NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ (NTII). They have made 6 open-market trades across 2 companies since 2006, most recently 2009-12-29.
CIK 0001008616
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $227K since 2006, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NTII | SELL | 2009-12-29 | 2009-12-30 | $0.12 | $673 | N/A | N/A | N/A |
| NTII | BUY | 2008-10-15 | 2008-10-16 | $0.85 | $9K | N/A | N/A | N/A |
| EFOI | BUY | 2008-03-14 | 2008-03-18 | $3.08 | $23K | -15.1% | -1.5% | -1.5% |
| NTII | BUY | 2007-12-03 | 2007-12-05 | $3.29 | $56K | N/A | N/A | N/A |
| NTII | BUY | 2007-11-02 | 2007-11-06 | $2.75 | $120K | N/A | N/A | N/A |
| NTII | BUY | 2006-03-03 | 2006-03-03 | $3.82 | $19K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.